|
|||||
|
|

Manufacturing company IDEX (NYSE:IEX) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 4.2% year on year to $899.1 million. Its non-GAAP profit of $2.10 per share was 2.9% above analysts’ consensus estimates.
Is now the time to buy IEX? Find out in our full research report (it’s free for active Edge members).
IDEX’s fourth quarter was marked by a positive market reaction, as management pointed to strong order momentum in its Health, Science, and Technology (HST) segment and continued expansion in key verticals like data centers and semiconductors. CEO Eric Ashleman highlighted the company’s ability to leverage its cross-business capabilities, noting, “Our performance pneumatics group is helping customers support data center construction driven by demand from artificial intelligence.” Margin expansion was also attributed to the company’s disciplined application of its 8020 operational strategy and focused cost containment.
Looking ahead, management’s outlook for 2026 is shaped by ongoing momentum in HST, but tempered by subdued expectations for industrial, chemical, and agricultural end markets. While CFO Sean Gillen emphasized positive order trends and the company’s ability to flex capacity with minimal capital outlays, he also cautioned that “volume decrementals offsetting price cost and productivity is our base assumption for both FMT and FSDP.” The team is focused on maximizing growth in higher-performing segments while maintaining operational discipline across the portfolio.
Management credited robust order growth in HST and targeted platform strategies as the main drivers behind Q4’s outperformance, while also acknowledging ongoing softness in traditional industrial markets.
Management expects growth in HST and municipal water to offset ongoing softness in industrial, chemical, and agricultural markets, shaping a cautious but opportunity-driven outlook for the next year.
In the coming quarters, the StockStory team will watch for (1) sustained order momentum and revenue conversion in the HST segment, especially from data center and semiconductor markets; (2) any signs of stabilization or recovery in industrial, chemical, and agricultural demand, which could provide incremental upside; and (3) progress integrating bolt-on acquisitions like Microlam and their impact on portfolio growth. The company’s capital allocation toward high-return investments and share repurchases also remains a key area of focus.
IDEX currently trades at $212.34, up from $201.61 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
| Apr-29 | |
| Apr-29 | |
| Apr-29 | |
| Apr-17 | |
| Apr-02 | |
| Mar-09 | |
| Mar-06 | |
| Mar-05 | |
| Feb-25 | |
| Feb-20 | |
| Feb-12 | |
| Feb-11 | |
| Feb-06 | |
| Feb-05 | |
| Feb-05 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite